.@CardiolRx Announces Study Demonstrating Its Proprietary Nanotechnology Targets Fibrous Tissue in the Heart https://t.co/bwYjFUOAFH $CRDL $CRTPF #heartfailure #nanotechnology #investing #stocks https://t.co/wvQ3ipncs0